tiprankstipranks
Trending News
More News >
Ars Pharmaceuticals, Inc. (SPRY)
:SPRY
US Market

ARS Pharmaceuticals (SPRY) Ratios

Compare
402 Followers

ARS Pharmaceuticals Ratios

SPRY's free cash flow for Q1 2025 was $0.00. For the 2025 fiscal year, SPRY's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
51.01 96.92 51.01 7.42 3.21
Quick Ratio
51.20 96.92 51.20 8.25 3.53
Cash Ratio
38.67 29.68 38.67 7.34 2.99
Solvency Ratio
-3.94 -22.36 -3.94 -0.22 0.02
Operating Cash Flow Ratio
-7.36 -24.79 -7.36 -2.14 1.10
Short-Term Operating Cash Flow Coverage
-174.25 0.00 -174.25 -5.05 3.55
Net Current Asset Value
$ -10.72M$ 229.30M$ 269.15M$ -31.98M$ -14.08M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 0.15 0.38
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 -0.29 -0.71
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 -0.41 -2.48
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 -0.19 -1.13
Financial Leverage Ratio
1.03 1.01 1.03 -1.97 -1.88
Debt Service Coverage Ratio
-151.40 0.00 -151.40 -5.30 -0.10
Interest Coverage Ratio
0.00 0.00 0.00 -183.53 -16.17
Debt to Market Cap
<0.01 0.00 <0.01 0.04 <0.01
Interest Debt Per Share
0.01 <0.01 0.01 0.32 0.29
Net Debt to EBITDA
-0.25 1.05 5.91 2.65 31.32
Profitability Margins
Gross Profit Margin
-1216.11%-143.33%-1216.11%-268.20%21.11%
EBIT Margin
-2698.78%-225066.67%-2698.78%-353.32%-2.63%
EBITDA Margin
-2698.78%-224823.33%-2698.78%-349.46%-2.60%
Operating Profit Margin
-2698.78%-225066.67%-2698.78%-353.32%-2.63%
Pretax Profit Margin
-2635.41%-181216.67%-2635.41%-367.65%-5.97%
Net Profit Margin
-2582.67%-181216.67%-2582.67%-367.65%-5.97%
Continuous Operations Profit Margin
-2635.41%-181216.67%-2635.41%-367.65%-5.97%
Net Income Per EBT
98.00%100.00%98.00%100.00%100.00%
EBT Per EBIT
97.65%80.52%97.65%104.06%227.08%
Return on Assets (ROA)
-153.17%-23.31%-12.08%-32.94%-4.03%
Return on Equity (ROE)
427.75%-23.56%-12.46%64.74%7.58%
Return on Capital Employed (ROCE)
1056.03%-29.26%-12.87%-36.53%-2.58%
Return on Invested Capital (ROIC)
-240.26%-29.23%-12.59%-33.81%-1.83%
Return on Tangible Assets
-153.17%-23.38%-12.08%-32.94%-4.03%
Earnings Yield
-2.90%-10.42%-9.97%-10.53%-0.07%
Efficiency Ratios
Receivables Turnover
0.00 0.04 0.00 5.51K 46.45
Payables Turnover
10.44 0.10 10.44 11.35 11.54
Inventory Turnover
-17.17 0.00 -17.17 -2.99 -5.39
Fixed Asset Turnover
1.70 0.04 1.70 7.95 775.43
Asset Turnover
<0.01 <0.01 <0.01 0.09 0.68
Working Capital Turnover Ratio
<0.01 <0.01 <0.01 0.16 3.31
Cash Conversion Cycle
-830.58 5.88K -56.23 -154.18 -91.47
Days of Sales Outstanding
0.00 9.67K 0.00 0.07 7.86
Days of Inventory Outstanding
0.00 0.00 -21.26 -122.09 -67.71
Days of Payables Outstanding
830.58 3.79K 34.96 32.16 31.62
Operating Cycle
0.00 9.67K -21.26 -122.02 -59.85
Cash Flow Ratios
Operating Cash Flow Per Share
-1.00 -0.62 -1.00 -0.61 0.26
Free Cash Flow Per Share
-1.01 -0.62 -1.01 -0.61 0.23
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 0.03
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 0.90
Dividend Paid and CapEx Coverage Ratio
-201.40 -338.66 -201.40 -319.29 9.89
Capital Expenditure Coverage Ratio
-201.40 -338.66 -201.40 -319.29 9.89
Operating Cash Flow Coverage Ratio
-83.32 -216.30 -83.32 -1.94 0.91
Operating Cash Flow to Sales Ratio
-30.45 -1.98K -30.45 -3.19 0.51
Free Cash Flow Yield
-2.30%-11.39%-11.82%-9.16%0.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-10.03 -9.60 -10.03 -9.50 -1.51K
Price-to-Sales (P/S) Ratio
258.99 17.39K 258.99 34.92 90.16
Price-to-Book (P/B) Ratio
1.25 2.26 1.25 -6.15 -114.44
Price-to-Free Cash Flow (P/FCF) Ratio
-8.46 -8.78 -8.46 -10.92 197.21
Price-to-Operating Cash Flow Ratio
-8.50 -8.80 -8.50 -10.95 177.27
Price-to-Earnings Growth (PEG) Ratio
-0.47 0.29 -0.47 >-0.01 15.77
Price-to-Fair Value
1.25 2.26 1.25 -6.15 -114.44
Enterprise Value Multiple
-3.68 -6.69 -3.68 -7.34 -3.44K
Enterprise Value
832.31M 451.08M 130.79M 141.26M 1.59B
EV to EBITDA
-36.96 -6.69 -3.68 -7.34 -3.44K
EV to Sales
0.00 15.04K 99.38 25.66 89.35
EV to Free Cash Flow
-43.82 -7.59 -3.25 -8.02 195.43
EV to Operating Cash Flow
-44.04 -7.61 -3.26 -8.04 175.68
Tangible Book Value Per Share
6.83 2.42 6.83 -1.08 -0.40
Shareholders’ Equity Per Share
6.83 2.42 6.83 -1.08 -0.40
Tax and Other Ratios
Effective Tax Rate
0.02 0.00 0.02 0.01 0.19
Revenue Per Share
0.03 <0.01 0.03 0.19 0.51
Net Income Per Share
-0.85 -0.57 -0.85 -0.70 -0.03
Tax Burden
1.00 1.00 0.98 1.00 1.00
Interest Burden
1.00 0.81 0.98 1.04 2.27
Research & Development to Revenue
0.00 675.53 13.96 3.68 0.79
SG&A to Revenue
0.00 1.58K 14.02 0.85 0.24
Stock-Based Compensation to Revenue
0.00 307.83 4.44 0.51 0.20
Income Quality
0.79 1.09 1.16 0.87 -8.52
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis